Yep, Vintage in particular has some nice positive volume today. I can't help but feel that we'll have results by the end of the week. Added bonus is that BYE is starting to move up nicely; to the point that our market cap only just exceeds the value of the BYE holding and cash. I can only see that situation improving over the next month with their G1 well coming into production (~2 weeks) and results from G2 (~3 weeks).
Base case success per a VEN announcement should be worth $17-20m to MEL. Strong flow rates, especially from the unbooked lower zone have a real chance of boosting that figure. BYE at 22c is roughly $8.75m + $20m for Vali and residual cash of $2m after Vali costs...call it $30m and round it to 600m shares on issue...circa 5c with no upside factored in and no valuation attributed to analogous prospects (Odin) or Cervantes. I don't think 7c would be too unreasonable in a success case. Many bridged still to cross, but looking ok atm.
- Forums
- ASX - By Stock
- Ann: Vali flow-back program update
MEL
metgasco ltd
Add to My Watchlist
0.00%
!
0.2¢

Yep, Vintage in particular has some nice positive volume today....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.665M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $7.983K | 3.511M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 9832429 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 11398095 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 9832429 | 0.002 |
8 | 35000998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 11398095 | 12 |
0.004 | 10479052 | 6 |
0.006 | 311675 | 1 |
0.020 | 15085 | 1 |
0.022 | 91666 | 1 |
Last trade - 11.48am 26/06/2025 (20 minute delay) ? |
Featured News
MEL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online